Advertisement
Some clinical departments tend to undertreat when prescribing statins

Many Physicians Show Tendency to Undertreat With Statins

0
Target levels more likely to be achieved in departments that prescribe more statins
Among patients who die in the intensive care unit

Palliative Care Lacking for Chronic Lung Disease Patients

0
Patients with lung diseases have fewer DNRs, pain assessments than cancer patients
Comorbidities in Parkinson's disease patients impact physicians' fitness-to-drive recommendations

Comorbidity Affects Fitness-to-Drive Recs in Parkinson’s Disease

0
Physicians consider comorbidities, but on-road assessors may not
In order to prevent hepatitis C virus infection among patients undergoing hemodialysis

CDC Issues Guidance to Stop HCV Transmission in Hemodialysis

0
Dialysis providers and facilities should assess and improve infection control practices
Mobile telephone text messaging may be a promising new way to improve adherence to medications for chronic diseases

Mobile Texts May Up Adherence to Meds for Chronic Illness

0
Meta-analysis shows mobile phone text reminders double the odds of medication adherence
Taking prescription opioids doesn't improve movement or reduce disability for patients with neuropathic pain

Opioids Don’t Ease Disability in Neuropathic Pain

0
Medications aren't useful in restoring motion, researchers say
Most flavored electronic cigarettes contain benzaldehyde

Many Flavored E-Cigarettes Contain Benzaldehyde

0
Highest levels in cherry-flavored e-cigarettes; levels >1,000-fold lower than those in workplace
Demand for medical office space for ambulatory care is at a high point and looks likely to continue increasing

Demand for Medical Office Space High and Increasing

0
Vacancy rate for medical office buildings 9.5 percent in third quarter of 2015; lowest since 2007
HIV resistance to the antiretroviral drug tenofovir (Viread) is common

High Level of Tenofovir Resistance for Those With HIV

0
Resistance affects almost two-thirds of those taking tenofovir in sub-Sahara Africa
Zepatier (elbasvir and grazoprevir) has been approved by the U.S. Food and Drug Administration to treat chronic hepatitis C virus genotypes 1 and 4 infections.

FDA Approves Zepatier for Chronic Hepatitis C

0
Medication indicated for patients with hepatitis C virus genotypes 1 and 4 infections